Israeli cell therapy could treat respiratory effects caused by coronavirus
“We will first approach COVID-19 patients through compassionate use so we can treat them immediately," Pluristem's CEO said.
Biologists work in a laboratory at Pluristem Therapeutics Inc. in Haifa(photo credit: BAZ RATNER/REUTERS)